| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.2 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.2 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |